Intraluminal gene transfer of endothelial cell-nitric oxide synthase suppresses intimai hyperplasia of vein grafts in cholesterol-fed rabbit: A limited biological effect as a result of the loss of medial smooth muscle cells

Shinji Ohta, Kimihiro Komori, Yoshikazu Yonemitsu, Toshihiro Onohara, takuya matsumoto, Keizo Sugimachi

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Background. The intimal hyperplasia of vein grafts is a major cause of late graft failure and is more pronounced under hyperlipidemia. We previously reported that endothelial cell (ec)-type nitric oxide synthase (NOS) gene transfer inhibited graft intimal hyperplasia under poor runoff conditions. However, little information is available on either ecNOS gene transfer or intimal thickening under hypercholesterolemia. Methods. Using the hemagglutinating virus of Japan liposomes, bovine ecNOS complentary DNA (5000 hemagglutinating activity units/mL) was transfected intraluminally to the right jugular vein, and these veins were then implanted as reversed vein grafts in an end-to-side fashion to the ipsilateral carotid artery. Results. The cyclic guanosine 3′,5′-monophosphate content of the ecNOS vein significantly increased in the grafts at 4 days after gene transfer, but the levels were only 25% greater than those found in the untreated veins. An immunohistochemical analysis at the same rime suggested a large loss of medial smooth muscle cells that might have led to a reduction in the exogenous gene expression. The neointima of the ecNOS grafts was significantly reduced 4 weeks after implantation (P < .05), but the effect of ecNOS was limited to about a 30% inhibition. This reduction was associated with a reduced population of proliferating cells and decreased macrophage accumulation in the graft wall. Conclusions. These results demonstrated that the ecNOS gene transfer suppressed intimal hyperplasia of the vein grafts under hyperlipidemic conditions. However, this effect may be limited because of the smooth muscle cell loss related to the use of an intraluminal delivery methods. These data lead to speculation that the outcome of ecNOS gene transfer could be improved using different methods of gene delivery.

Original languageEnglish
Pages (from-to)644-653
Number of pages10
JournalSurgery
Volume131
Issue number6
DOIs
Publication statusPublished - Jan 1 2002

Fingerprint

Nitric Oxide Synthase Type III
Smooth Muscle Myocytes
Hyperplasia
Veins
Endothelial Cells
Cholesterol
Tunica Intima
Rabbits
Transplants
Genes
Guanosine Monophosphate
Sendai virus
Neointima
Jugular Veins
Hypercholesterolemia
Hyperlipidemias
Carotid Arteries
Liposomes
Macrophages
Gene Expression

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Intraluminal gene transfer of endothelial cell-nitric oxide synthase suppresses intimai hyperplasia of vein grafts in cholesterol-fed rabbit : A limited biological effect as a result of the loss of medial smooth muscle cells. / Ohta, Shinji; Komori, Kimihiro; Yonemitsu, Yoshikazu; Onohara, Toshihiro; matsumoto, takuya; Sugimachi, Keizo.

In: Surgery, Vol. 131, No. 6, 01.01.2002, p. 644-653.

Research output: Contribution to journalArticle

@article{b8ef9e7b867b45fc9b64a024fd11e437,
title = "Intraluminal gene transfer of endothelial cell-nitric oxide synthase suppresses intimai hyperplasia of vein grafts in cholesterol-fed rabbit: A limited biological effect as a result of the loss of medial smooth muscle cells",
abstract = "Background. The intimal hyperplasia of vein grafts is a major cause of late graft failure and is more pronounced under hyperlipidemia. We previously reported that endothelial cell (ec)-type nitric oxide synthase (NOS) gene transfer inhibited graft intimal hyperplasia under poor runoff conditions. However, little information is available on either ecNOS gene transfer or intimal thickening under hypercholesterolemia. Methods. Using the hemagglutinating virus of Japan liposomes, bovine ecNOS complentary DNA (5000 hemagglutinating activity units/mL) was transfected intraluminally to the right jugular vein, and these veins were then implanted as reversed vein grafts in an end-to-side fashion to the ipsilateral carotid artery. Results. The cyclic guanosine 3′,5′-monophosphate content of the ecNOS vein significantly increased in the grafts at 4 days after gene transfer, but the levels were only 25{\%} greater than those found in the untreated veins. An immunohistochemical analysis at the same rime suggested a large loss of medial smooth muscle cells that might have led to a reduction in the exogenous gene expression. The neointima of the ecNOS grafts was significantly reduced 4 weeks after implantation (P < .05), but the effect of ecNOS was limited to about a 30{\%} inhibition. This reduction was associated with a reduced population of proliferating cells and decreased macrophage accumulation in the graft wall. Conclusions. These results demonstrated that the ecNOS gene transfer suppressed intimal hyperplasia of the vein grafts under hyperlipidemic conditions. However, this effect may be limited because of the smooth muscle cell loss related to the use of an intraluminal delivery methods. These data lead to speculation that the outcome of ecNOS gene transfer could be improved using different methods of gene delivery.",
author = "Shinji Ohta and Kimihiro Komori and Yoshikazu Yonemitsu and Toshihiro Onohara and takuya matsumoto and Keizo Sugimachi",
year = "2002",
month = "1",
day = "1",
doi = "10.1067/msy.2002.124878",
language = "English",
volume = "131",
pages = "644--653",
journal = "Surgery",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Intraluminal gene transfer of endothelial cell-nitric oxide synthase suppresses intimai hyperplasia of vein grafts in cholesterol-fed rabbit

T2 - A limited biological effect as a result of the loss of medial smooth muscle cells

AU - Ohta, Shinji

AU - Komori, Kimihiro

AU - Yonemitsu, Yoshikazu

AU - Onohara, Toshihiro

AU - matsumoto, takuya

AU - Sugimachi, Keizo

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Background. The intimal hyperplasia of vein grafts is a major cause of late graft failure and is more pronounced under hyperlipidemia. We previously reported that endothelial cell (ec)-type nitric oxide synthase (NOS) gene transfer inhibited graft intimal hyperplasia under poor runoff conditions. However, little information is available on either ecNOS gene transfer or intimal thickening under hypercholesterolemia. Methods. Using the hemagglutinating virus of Japan liposomes, bovine ecNOS complentary DNA (5000 hemagglutinating activity units/mL) was transfected intraluminally to the right jugular vein, and these veins were then implanted as reversed vein grafts in an end-to-side fashion to the ipsilateral carotid artery. Results. The cyclic guanosine 3′,5′-monophosphate content of the ecNOS vein significantly increased in the grafts at 4 days after gene transfer, but the levels were only 25% greater than those found in the untreated veins. An immunohistochemical analysis at the same rime suggested a large loss of medial smooth muscle cells that might have led to a reduction in the exogenous gene expression. The neointima of the ecNOS grafts was significantly reduced 4 weeks after implantation (P < .05), but the effect of ecNOS was limited to about a 30% inhibition. This reduction was associated with a reduced population of proliferating cells and decreased macrophage accumulation in the graft wall. Conclusions. These results demonstrated that the ecNOS gene transfer suppressed intimal hyperplasia of the vein grafts under hyperlipidemic conditions. However, this effect may be limited because of the smooth muscle cell loss related to the use of an intraluminal delivery methods. These data lead to speculation that the outcome of ecNOS gene transfer could be improved using different methods of gene delivery.

AB - Background. The intimal hyperplasia of vein grafts is a major cause of late graft failure and is more pronounced under hyperlipidemia. We previously reported that endothelial cell (ec)-type nitric oxide synthase (NOS) gene transfer inhibited graft intimal hyperplasia under poor runoff conditions. However, little information is available on either ecNOS gene transfer or intimal thickening under hypercholesterolemia. Methods. Using the hemagglutinating virus of Japan liposomes, bovine ecNOS complentary DNA (5000 hemagglutinating activity units/mL) was transfected intraluminally to the right jugular vein, and these veins were then implanted as reversed vein grafts in an end-to-side fashion to the ipsilateral carotid artery. Results. The cyclic guanosine 3′,5′-monophosphate content of the ecNOS vein significantly increased in the grafts at 4 days after gene transfer, but the levels were only 25% greater than those found in the untreated veins. An immunohistochemical analysis at the same rime suggested a large loss of medial smooth muscle cells that might have led to a reduction in the exogenous gene expression. The neointima of the ecNOS grafts was significantly reduced 4 weeks after implantation (P < .05), but the effect of ecNOS was limited to about a 30% inhibition. This reduction was associated with a reduced population of proliferating cells and decreased macrophage accumulation in the graft wall. Conclusions. These results demonstrated that the ecNOS gene transfer suppressed intimal hyperplasia of the vein grafts under hyperlipidemic conditions. However, this effect may be limited because of the smooth muscle cell loss related to the use of an intraluminal delivery methods. These data lead to speculation that the outcome of ecNOS gene transfer could be improved using different methods of gene delivery.

UR - http://www.scopus.com/inward/record.url?scp=0036088832&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036088832&partnerID=8YFLogxK

U2 - 10.1067/msy.2002.124878

DO - 10.1067/msy.2002.124878

M3 - Article

C2 - 12075177

AN - SCOPUS:0036088832

VL - 131

SP - 644

EP - 653

JO - Surgery

JF - Surgery

SN - 0039-6060

IS - 6

ER -